Osteosarcoma
What's New
Last Posted: Apr 05, 2022
- Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram.
Zhong Jingyu et al. European radiology 2022 - Cancer risk among RECQL4 heterozygotes.
Martin-Giacalone Bailey A et al. Cancer genetics 2022 262-263107-110 - Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
Teo Ka Yaw et al. PloS one 2022 17(2) e0259564 - Effectiveness of Learning Systems from Common Image File Types to Detect Osteosarcoma Based on Convolutional Neural Networks (CNNs) Models.
Loraksa Chanunya et al. Journal of imaging 2022 8(1) - Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
Zhang Lu et al. Frontiers in oncology 2021 11758921 - Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto Tadashi et al. International journal of clinical oncology 2021 - Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Liu Wangmi et al. JAMA network open 2021 4(8) e2119132 - Machine learning-based CT radiomics features for the prediction of pulmonary metastasis in osteosarcoma.
Pereira Helcio Mendonça et al. The British journal of radiology 2021 20201391 - 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
Rothzerg Emel et al. Experimental biology and medicine (Maywood, N.J.) 2021 15353702211007410 - Predictive model for the 5-year survival status of osteosarcoma patients based on the SEER database and XGBoost algorithm.
Jiang Jiuzhou et al. Scientific reports 2021 11(1) 5542
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 01, 2022
- Content source: